Skip to content
Class Notes

Johnson & Johnson - GB 540 Economics For Global Decision Makers

This Project PPT provides an economic analysis of Johnson & Johnson�s strategies in global markets.

Preview 12 of 37 pages

See the first 12 pages exactly as they appear in the document.

  1. Page 1
    Read page 1 as text

    Johnson & Johnson Bill Justice GB 540 Economics for Global Decision Makers International Economic and Emerging Economies - Final Project November 23, 2010

  2. Page 2
  3. Page 3
    Read page 3 as text

    Company History ◼ Founded in 1885, New Brunswick, NJ ◼ By the Johnson brothers Robert, James, and Edward ◼ Started with 14 employees in a former wallpaper factory ◼ First product was surgical dressings

  4. Page 4
    Read page 4 as text

    Company Overview ◼ The world's largest healthcare group ◼ R&D, manufacture, and sale of a range of products in the healthcare field ◼ Operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics ◼ 115,000 employees worldwide ◼ More than 250 operating companies ◼ Sell products in 60 countries throughout the world

  5. Page 5
    Read page 5 as text

    Product Categories Allergies Baby Care Dental Care Diabetes Care Feminine Hygiene Gastrointestinal Nutritional Orthopedics Prescription Drugs Vision Care Wound Care Colds and Flu Cardiology Denture Care Family Planning First Aid Medial Devices/Diagnostics Oncology Pain Reliever Skin and Hair Care Women’s Health

  6. Page 6
    Read page 6 as text

    Corporate Leadership

  7. Page 7
    Read page 7 as text

    Management ◼ Weldon Williams - (1971) CEO ◼ Joined the company in 1971 ◼ Served in several sales, marketing and international management positions ◼ Dominic Caruso - (1999) CFO & Vice President of Finance ◼ Previously VP of the Finance for the Medical Devices and Diagnostics ◼ KPMG ◼ Joined in October of 1999 through the acquisition of Centocor (has been with that company since 1985) ◼ Russell C. Deyo - (1985) Vice President, Human Resources and General Counsel ◼ Joined the company in 1985 as a general attorney ◼ Previously VP of Administration, named to post in 1996 ◼ Appointed to General Counsel in April 2004 ◼ Given additional responsibility for Human Resources in 2009 Strong Sense of Seniority

  8. Page 8
    Read page 8 as text

    Current Financial Status

  9. Page 9
    Read page 9 as text

    Highlights ◼ A stable and strong company that meets all the needs of a stock an investor should have going into a recession ◼ DIVERSIFICATION - not only produces medication, but also medical equipment, and human staple goods ◼ Unlike many other pharmaceutical companies, they are not in big trouble with patents ◼ Proven successful during the recent recessions

  10. Page 10
    Read page 10 as text

    Performance in 2001 Recession Had a 2:1 stock split during the recession Performance in Past Recession JNJ Adjusted Close DJIA

  11. Page 11
    Read page 11 as text

    Track Record of Performance ◼ Exceptionally consistent performance ◼ 75 consecutive years of sales increases ◼ 24 consecutive years of earnings increases ◼ 45 consecutive years of dividend increases ◼ Few, if any companies, can claim this

  12. Page 12
    Read page 12 as text

    JNJ Common Stock Johnson & Johnson Common Stock (NYSE: JNJ ) After Hours: 63.85 0.02 (0.03%) 7:58PM EST ◼ Last Trade: 63.83 ◼ Trade Time: Nov 19 ◼ Change: 0.00 (0.00%) ◼ Prev Close: 63.83 ◼ Open: 63.89 ◼ Bid: 63.72 x 300 ◼ Ask: 63.95 x 200 ◼ 1y Target Est: 67.84 ◼ Day's Range: 63.65 - 64.22 ◼ 52wk Range: 56.86 - 66.20 ◼ Volume: 12,890,323 ◼ Avg Vol (3m): 10,326,100 ◼ Market Cap: 175.29B ◼ P/E (ttm): 13.11 ◼ EPS (ttm): 4.87 ◼ Div & Yield: 2.16 (3.40%) Source: Yahoo Finance

25 more pages in the full document

Unlock it once and it stays in your library, ready to chat with or turn into flashcards.

Unlock the full document

More Economics study materials

See all

Study this document with CramX

Once it is in your library, every tool can work from it.